185 related articles for article (PubMed ID: 250503)
1. Ventricular tachycardia-flutter associated with disopyramide therapy: a report of three cases.
Dhurandhar RW; Nademanee K; Goldman AM
Heart Lung; 1978; 7(5):783-7. PubMed ID: 250503
[TBL] [Abstract][Full Text] [Related]
2. Ventricular tachycardia with torsade de pointes morphology induced by oral disopyramide.
Commerford PJ; Beck W
S Afr Med J; 1980 Sep; 58(11):447-8. PubMed ID: 7404173
[TBL] [Abstract][Full Text] [Related]
3. Torsade de pointes ventricular tachycardia. A complication of disopyramide shared with quinidine.
Wald RW; Waxman MB; Colman JM
J Electrocardiol; 1981 Jul; 14(3):301-7. PubMed ID: 7264507
[TBL] [Abstract][Full Text] [Related]
4. Ventricular tachyarrhythmias induced by disopyramide and other similar anti-arrhythmic drugs.
Croft CH; Kennelly BM
S Afr Med J; 1981 Jun; 59(24):871-3. PubMed ID: 7233313
[TBL] [Abstract][Full Text] [Related]
5. Drug-induced torsade de pointes.
Raehl CL; Patel AK; LeRoy M
Clin Pharm; 1985; 4(6):675-90. PubMed ID: 2416504
[TBL] [Abstract][Full Text] [Related]
6. Disopyramide-induced Torsade de Pointes.
Tzivoni D; Keren A; Stern S; Gottlieb S
Arch Intern Med; 1981 Jun; 141(7):946-7. PubMed ID: 7235820
[TBL] [Abstract][Full Text] [Related]
7. [Paradoxic response to disopyramide and quinidine (author's transl)].
Breithardt G; Seipel L; Haerten K
Z Kardiol; 1980 Aug; 69(8):556-61. PubMed ID: 7445656
[TBL] [Abstract][Full Text] [Related]
8. Disopyramide-induced ventricular fibrillation.
Nicholson WJ; Martin CE; Gracey JG; Knoch HR
Am J Cardiol; 1979 May; 43(5):1053-5. PubMed ID: 433766
[TBL] [Abstract][Full Text] [Related]
9. Quinidine syncope: torsade de pointes with low quinidine plasma concentrations.
Jenzer HR; Hagemeijer F
Eur J Cardiol; 1976 Dec; 4(4):447-51. PubMed ID: 63370
[TBL] [Abstract][Full Text] [Related]
10. [Atypical ventricular tachycardia due to disopyramide].
Feigl D; Ashkenazi J; Schwarzmann H
Harefuah; 1982 Mar; 102(6):246-7. PubMed ID: 7160719
[No Abstract] [Full Text] [Related]
11. Atypical ventricular tachycardia as a manifestation of disopyramide toxicity.
Meltzer RS; Robert EW; McMorrow M; Martin RP
Am J Cardiol; 1978 Dec; 42(6):1049-53. PubMed ID: 727132
[TBL] [Abstract][Full Text] [Related]
12. Disopyramide-induced ventricular tachycardia.
Lo KS; Gantz KB; Stetson PL; Lucchesi BR; Pitt B
Arch Intern Med; 1980 Mar; 140(3):413-4. PubMed ID: 6153888
[TBL] [Abstract][Full Text] [Related]
13. Overdrive pacing in quinidine syncope and other long QT-interval syndromes.
DiSegni E; Klein HO; David D; Libhaber C; Kaplinsky E
Arch Intern Med; 1980 Aug; 140(8):1036-40. PubMed ID: 7396607
[TBL] [Abstract][Full Text] [Related]
14. Atypical ventricular tachycardia (torsade de pointes) induced by amiodarone: arrhythmia previously induced by quinidine and disopyramide.
Keren A; Tzivoni D; Gottlieb S; Benhorin J; Stern S
Chest; 1982 Mar; 81(3):384-6. PubMed ID: 7056119
[TBL] [Abstract][Full Text] [Related]
15. [Intravenously disopyramide phosphate administration for treatment of arrhythmias].
Aquaro G; Belli R; Pavia M; Rey L; Ravera A; Possavino G; Idone P
G Ital Cardiol; 1982; 12(7):509-19. PubMed ID: 7169147
[TBL] [Abstract][Full Text] [Related]
16. [Ventricular fibrillation during disopyramide treatment].
Edhag O; Forssell G; Schenck-Gustafsson K
Lakartidningen; 1981 Oct; 78(41):3597-600. PubMed ID: 7321703
[No Abstract] [Full Text] [Related]
17. Disopyramide induced atypical ventricular tachycardia.
Chia BL
Aust N Z J Med; 1980 Dec; 10(6):665-8. PubMed ID: 6938189
[TBL] [Abstract][Full Text] [Related]
18. Disopyramide-induced syncope.
Tri TB
Am J Cardiol; 1979 Aug; 44(2):391-2. PubMed ID: 463780
[No Abstract] [Full Text] [Related]
19. Clinical studies of Norpace. Summarizing remarks.
Fowler NO
Angiology; 1975 Jan; 26(1 Pt 2):154-5. PubMed ID: 1090216
[No Abstract] [Full Text] [Related]
20. Extreme tachycardia complicating the use of disopyramide in atrial flutter.
Robertson CE; Miller HC
Br Heart J; 1980 Nov; 44(5):602-3. PubMed ID: 7437205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
